Regulator flags 49 drug samples as substandard, four as spurious

2 hours ago 1

CDSCOThe database of drugs, flagged by the Central Drugs Standard Control Organisation (CDSCO) successful its monthly survey report, besides contained metformin, utilized successful the attraction of diabetes, too paracetamol. (File Photo)

The apex cause regulator has recovered samples of 4 drugs, including the commonly utilized calcium supplement Shelcal 500 and antacid Pan D, arsenic spurious, portion samples of 49 others were listed arsenic Not of Standard Quality (NSQ).

The database of drugs, flagged by the Central Drugs Standard Control Organisation (CDSCO) successful its monthly survey report, besides contained metformin, utilized successful the attraction of diabetes, too paracetamol.

The survey was portion of a regular workout by the cause regulator during which medicines are randomly tested for quality.

Drug Controller General of India Dr Rajeev Singh Raghuvanshi said the NSQ drugs had “failed successful immoderate of the specified… prime parameters”. “And past determination are 4 spurious drugs. These person not been manufactured by the brands that person been mentioned connected the packaging,” helium said. All medicines named successful the NSQ database bash not person immoderate prime problem. Only the medicine manufactured by the peculiar institution and the peculiar batch mentioned successful the database has failed connected prime parameters,” Raghuvanshi added.

Raghuvanshi said that astir 3,000 samples are tested each period and “around 1.5% neglect connected mean a month”.

© The Indian Express Pvt Ltd

First uploaded on: 26-10-2024 astatine 02:37 IST

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Nandigram Times

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.nandigramtimes.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article